ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 720 filers reported holding ISHARES TR in Q4 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $260,007 | -3.8% | 2,126 | -0.1% | 0.08% | 0.0% |
| Q2 2023 | $270,190 | -15.7% | 2,128 | -14.3% | 0.08% | -20.2% |
| Q1 2023 | $320,594 | -1.6% | 2,482 | 0.0% | 0.10% | -7.5% |
| Q4 2022 | $325,873 | +12.4% | 2,482 | +0.1% | 0.11% | +4.9% |
| Q3 2022 | $290,000 | -0.3% | 2,480 | 0.0% | 0.10% | +7.4% |
| Q2 2022 | $291,000 | +22.3% | 2,480 | +35.5% | 0.10% | +39.7% |
| Q1 2022 | $238,000 | -14.7% | 1,830 | 0.0% | 0.07% | -10.5% |
| Q4 2021 | $279,000 | -5.7% | 1,830 | 0.0% | 0.08% | -10.6% |
| Q3 2021 | $296,000 | -2.3% | 1,830 | 0.0% | 0.08% | 0.0% |
| Q2 2021 | $303,000 | +10.2% | 1,830 | 0.0% | 0.08% | -5.6% |
| Q1 2021 | $275,000 | -0.4% | 1,830 | +0.6% | 0.09% | -2.2% |
| Q4 2020 | $276,000 | +12.2% | 1,819 | 0.0% | 0.09% | -12.4% |
| Q3 2020 | $246,000 | -2.0% | 1,819 | -1.1% | 0.10% | -7.9% |
| Q2 2020 | $251,000 | +24.3% | 1,839 | -2.1% | 0.11% | +1.8% |
| Q1 2020 | $202,000 | -20.2% | 1,879 | -10.7% | 0.11% | -2.6% |
| Q4 2019 | $253,000 | – | 2,105 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |